Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 29

1.

A retrospective observational study of rituximab treatment in multiple sclerosis patients in Cyprus.

Leonidou E, Pantzaris M, Kleopa KA, Loizidou MA, Kyriakides T, Christou YP.

Postgrad Med. 2019 Jul 30:1-4. doi: 10.1080/00325481.2019.1649975. [Epub ahead of print]

PMID:
31353999
2.

Complete sequence analysis of human toll-like receptor 3 gene in natural killer cells of multiple sclerosis patients.

Deeba E, Koptides D, Lambrianides A, Pantzaris M, Krashias G, Christodoulou C.

Mult Scler Relat Disord. 2019 Aug;33:100-106. doi: 10.1016/j.msard.2019.05.027. Epub 2019 May 30.

3.

Gene variants of adhesion molecules predispose to MS: A case-control study.

Dardiotis E, Panayiotou E, Siokas V, Aloizou AM, Christodoulou K, Hadjisavvas A, Pantzaris M, Grigoriadis N, Hadjigeorgiou GM, Kyriakides T.

Neurol Genet. 2019 Jan 16;5(1):e304. doi: 10.1212/NXG.0000000000000304. eCollection 2019 Feb.

4.

Evaluation of Epstein-Barr virus-specific antibodies in Cypriot multiple sclerosis patients.

Deeba E, Koptides D, Gaglia E, Constantinou A, Lambrianides A, Pantzaris M, Krashias G, Christodoulou C.

Mol Immunol. 2019 Jan;105:270-275. doi: 10.1016/j.molimm.2018.12.010. Epub 2018 Dec 15.

5.

Does Natalizumab Induce or Aggravate Psoriasis? A Case Study and Review of the Literature.

Lambrianides S, Kinnis E, Leonidou E, Pantzaris M.

Case Rep Neurol. 2018 Sep 18;10(3):286-291. doi: 10.1159/000492891. eCollection 2018 Sep-Dec.

6.

Biochemical Characterization of the GBA2 c.1780G>C Missense Mutation in Lymphoblastoid Cells from Patients with Spastic Ataxia.

Malekkou A, Samarani M, Drousiotou A, Votsi C, Sonnino S, Pantzaris M, Chiricozzi E, Zamba-Papanicolaou E, Aureli M, Loberto N, Christodoulou K.

Int J Mol Sci. 2018 Oct 10;19(10). pii: E3099. doi: 10.3390/ijms19103099.

7.

The possible role of an autoimmune mechanism in the etiopathogenesis of Parkinson's disease.

Dalitis S, Filippidou N, Krashias G, Christodoulou C, Pantzaris M, Lambrianides A.

J Clin Neurosci. 2018 Aug;54:63-68. doi: 10.1016/j.jocn.2018.06.004. Epub 2018 Jun 12.

PMID:
29907389
8.

Restless legs syndrome in Multiple Sclerosis patients: a contributing factor for fatigue, impaired functional capacity, and diminished health-related quality of life.

Giannaki CD, Aristotelous P, Stefanakis M, Hadjigeorgiou GM, Manconi M, Leonidou E, Sakkas GK, Pantzaris M.

Neurol Res. 2018 Jul;40(7):586-592. doi: 10.1080/01616412.2018.1454719. Epub 2018 Mar 26.

PMID:
29577828
9.

Effects of controlled dehydration on sleep quality and quantity: A polysomnographic study in healthy young adults.

Aristotelous P, Aphamis G, Sakkas GK, Andreou E, Pantzaris M, Kyprianou T, Hadjigeorgiou GM, Manconi M, Giannaki CD.

J Sleep Res. 2019 Jun;28(3):e12662. doi: 10.1111/jsr.12662. Epub 2018 Feb 7.

PMID:
29411452
10.

Restless legs syndrome in adolescents: relationship with sleep quality, cardiorespiratory fitness and body fat.

Giannaki CD, Hadjigeorgiou GM, Aphamis G, Pantzaris M, Sakkas GK.

Sleep Sci. 2017 Jan-Mar;10(1):7-10. doi: 10.5935/1984-0063.20170002.

11.

Restless legs syndrome is contributing to fatigue and low quality of life levels in hemodialysis patients.

Giannaki CD, Hadjigavriel M, Lazarou A, Michael A, Damianou L, Atmatzidis E, Stefanidis I, Hadjigeorgiou GM, Sakkas GK, Pantzaris M.

World J Nephrol. 2017 Sep 6;6(5):236-242. doi: 10.5527/wjn.v6.i5.236.

12.

Real-Time Adaptation to Time-Varying Constraints for Medical Video Communications.

Antoniou ZC, Panayides AS, Pantzaris M, Constantinides AG, Pattichis CS, Pattichis MS, Antoniou ZC, Panayides AS, Pantzaris M, Constantinides AG, Pattichis CS, Pattichis MS.

IEEE J Biomed Health Inform. 2018 Jul;22(4):1177-1188. doi: 10.1109/JBHI.2017.2726180. Epub 2017 Jul 12.

PMID:
28708565
13.

Gene variants of adhesion molecules act as modifiers of disease severity in MS.

Dardiotis E, Panayiotou E, Provatas A, Christodoulou K, Hadjisavvas A, Antoniades A, Lourbopoulos A, Pantzaris M, Grigoriadis N, Hadjigeorgiou GM, Kyriakides T.

Neurol Neuroimmunol Neuroinflamm. 2017 Apr 24;4(4):e350. doi: 10.1212/NXI.0000000000000350. eCollection 2017 Jul.

14.

The association between IgG and IgM antibodies against cardiolipin, β2-glycoprotein I and Domain I of β2-glycoprotein I with disease profile in patients with multiple sclerosis.

Filippidou N, Krashias G, Pericleous C, Rahman A, Ioannou Y, Giles I, Demetriou C, Anatolitou A, Christodoulou C, Pantzaris M, Lambrianides A.

Mol Immunol. 2016 Jul;75:161-7. doi: 10.1016/j.molimm.2016.05.022. Epub 2016 Jun 9.

PMID:
27289032
15.

Minimally symptomatic mcardle disease, expanding the genotype-phenotype spectrum.

Petrou P, Pantzaris M, Dionysiou M, Drousiotou A, Kyriakides T.

Muscle Nerve. 2015 Nov;52(5):891-5. doi: 10.1002/mus.24716. Epub 2015 Jun 30.

PMID:
26032558
16.

Cervical vestibular evoked myogenic potentials in cerebellar lesions.

Papacostas SS, Papathanasiou ES, Kyriakides T, Pantzaris M.

Otol Neurotol. 2014 Oct;35(9):1633-7. doi: 10.1097/MAO.0000000000000462.

PMID:
24914793
17.

A novel GBA2 gene missense mutation in spastic ataxia.

Votsi C, Zamba-Papanicolaou E, Middleton LT, Pantzaris M, Christodoulou K.

Ann Hum Genet. 2014 Jan;78(1):13-22. doi: 10.1111/ahg.12045. Epub 2013 Nov 20.

18.

Epidemiology, impact, and treatment options of restless legs syndrome in end-stage renal disease patients: an evidence-based review.

Giannaki CD, Hadjigeorgiou GM, Karatzaferi C, Pantzaris MC, Stefanidis I, Sakkas GK.

Kidney Int. 2014 Jun;85(6):1275-82. doi: 10.1038/ki.2013.394. Epub 2013 Oct 9. Review.

19.
20.

Investigation of SCA10 in the Cypriot population: further exclusion of SCA dynamic repeat mutations.

Votsi C, Zamba-Papanicolaou E, Georghiou A, Kyriakides T, Papacostas S, Kleopa KA, Pantzaris M, Christodoulou K.

J Neurol Sci. 2012 Dec 15;323(1-2):154-7. doi: 10.1016/j.jns.2012.09.006. Epub 2012 Sep 29.

PMID:
23026538
21.

RET proto-oncogene mutations are restricted to codon 618 in Cypriot families with multiple endocrine neoplasia 2.

Neocleous V, Skordis N, Portides G, Efstathiou E, Costi C, Ioannou N, Pantzaris M, Anastasiadou V, Deltas C, Phylactou LA.

J Endocrinol Invest. 2011 Nov;34(10):764-9. doi: 10.3275/7605. Epub 2011 Mar 21.

PMID:
21422799
22.

Brainstem lesions may be important in the development of epilepsy in multiple sclerosis patients: an evoked potential study.

Papathanasiou ES, Pantzaris M, Myrianthopoulou P, Kkolou E, Papacostas SS.

Clin Neurophysiol. 2010 Dec;121(12):2104-10. doi: 10.1016/j.clinph.2010.05.017. Epub 2010 Jun 12.

PMID:
20542465
23.

A new neurogenic vestibular evoked potential (N6) recorded with the use of air-conducted sound.

Papathanasiou ES, Lemesiou A, Hadjiloizou S, Myrianthopoulou P, Pantzaris M, Papacostas SS.

Otol Neurotol. 2010 Apr;31(3):528-35. doi: 10.1097/MAO.0b013e3181cdd6b7.

PMID:
20104196
24.

Vertigo and imbalance caused by a small lesion in the anterior insula.

Papathanasiou ES, Papacostas SS, Charalambous M, Eracleous E, Thodi C, Pantzaris M.

Electromyogr Clin Neurophysiol. 2006 May-Jun;46(3):185-92.

PMID:
16918202
25.

Vestibular symptoms and signs are correlated with abnormal neurogenic vestibular evoked potentials in patients with multiple sclerosis.

Papathanasiou ES, Piperidou C, Pantzaris M, Iliopoulos I, Petsa M, Kyriakides T, Kleopa KA, Papacostas SS.

Electromyogr Clin Neurophysiol. 2005 Jun;45(4):195-201.

PMID:
16083141
26.

Unobtainable radial nerve F-waves in a case of radial nerve conduction block.

Papathanasiou E, Kleopa KA, Pantzaris M.

Electromyogr Clin Neurophysiol. 2004 Dec;44(8):451-4.

PMID:
15646001
27.

Neurogenic vestibular evoked potentials in the diagnosis of multiple sclerosis.

Papathanasiou ES, Pantzaris M, Zamba-Papanicolaou E, Kyriakides T, Kleopa KA, Iliopoulos I, Piperidou C, Papacostas S.

Electromyogr Clin Neurophysiol. 2004 Jul-Aug;44(5):313-7.

PMID:
15378872
28.

Spectrum and prevalence of prothrombotic single nucleotide polymorphism profiles in the Greek Cypriot population.

Xenophontos SL, Hadjivassiliou M, Ayrton N, Karagrigoriou A, Pantzaris M, Nicolaides AN, Cariolou MA.

Int Angiol. 2002 Dec;21(4):322-9.

PMID:
12518110
29.

Chromosome 17p-linked myasthenias stem from defects in the acetylcholine receptor epsilon-subunit gene.

Middleton L, Ohno K, Christodoulou K, Brengman J, Milone M, Neocleous V, Serdaroğlu P, Deymeer F, Ozdemir C, Mubaidin A, Horany K, Al-Shehab A, Mavromatis I, Mylonas I, Tsingis M, Zamba E, Pantzaris M, Kyriallis K, Engel AG.

Neurology. 1999 Sep 22;53(5):1076-82.

PMID:
10496269

Supplemental Content

Loading ...
Support Center